Summary
Type 2 (non-insulin-dependent) diabetes mellitus is characterised by hyperglycaemia, peripheral insulin resistance, impaired insulin secretion and pancreatic islet amyloid formation. The major constituent of islet amyloid is islet amyloid polypeptide (amylin). Islet amyloid polypeptide is synthesized by islet beta cells and co-secreted with insulin. The ability of islet amyloid polypeptide to form amyloid fibrils is related to its species-specific amino acid sequence. Islet amyloid associated with diabetes is only found in man, monkeys, cats and racoons. Pharmacological doses of islet amyloid polypeptide have been shown to inhibit insulin secretion as well as insulin action on peripheral tissues (insulin resistance). To examine the role of islet amyloid polypeptide in the pathogenesis of Type 2 diabetes, we have generated transgenic mice with the gene encoding either human islet amyloid polypeptide (which can form amyloid) or rat islet amyloid polypeptide, under control of an insulin promoter. Transgenic islet amyloid polypeptide mRNA was detected in the pancreas in all transgenic mice. Plasma islet amyloid polypeptide levels were significantly elevated (up to 15-fold) in three out of five transgenic lines, but elevated glucose levels, hyperinsulinaemia and obesity were not observed. This suggests that insulin resistance is not induced by chronic hypersecretion of islet amyloid polypeptide. Islet amyloid polypeptide immunoreactivity was localized to beta-cell secretory granules in all mice. Islet amyloid polypeptide immunoreactivity in beta-cell lysosomes was seen only in mice with the human islet amyloid polypeptide gene, as in human beta cells, and might represent an initial step in intracellular formation of amyloid fibrils. These transgenic mice provide a unique model with which to examine the physiological function of islet amyloid polypeptide and to study intracellular and extracellular handling of human islet amyloid polypeptide in pancreatic islets.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881–3885
Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628–8632
Cooper GJS, Leighton B, Dimitriadis GD et al. (1988) Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci USA 85: 7763–7766
Johnson KH, O'Brien TD, Betsholtz C, Westermark P (1989) Islet amyloid, islet amyloid polypeptide, and diabetes mellitus. N Engl J Med 321: 513–518
Ferrier GJM, Pierson AM, Jones PM, Bloom SR, Girgis SI, Legon S, (1989) Expression of the rat amylin (IAPP/DAP) gene. J Mol Endocrinol 3: R1-R4
Kahn SE, D'Alessio DA, Schwartz MW et al. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39: 634–638
Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87: 5036–5040
O'Brien TD, Westermark P, Johnson KH (1990) Islet amyloid polypeptide and calcitonin gene-related peptide immunoreactivity in amyloid and tumor-cells of canine pancreatic endocrine tumors. Vet Pathol 27: 194–198
Christmanson L, Betsholtz C, Leckström A et al. (1993) Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabetologia 36: 183–188
Nishi M, Chan SJ, Nagamatsu S, Bell GI, Steiner DF (1989) Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci USA 86: 5738–5742
Mosselman S, Höppener JWM, Zandberg J et al. (1988) Islet amyloid polypeptide: identification and chromosomal localization of the human gene. FEBS Lett 239: 227–232
Nishi M, Bell GI, Steiner DF (1990) Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 628–630
Ohsawa H, Kanatsuka A, Yamaguchi T, Makino H, Yoshida S (1989) Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun 160: 961–967
Silvestre RA, Peiro E, Dégano P, Miralles P, Marco J (1990) Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept 31: 23–31
Kogire M, Ishizuka J, Thompson JC, Greely GH Jr (1991) Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas. Pancreas 6: 459–463
Dégano P, Silvestre RA, Salas M, Peiro E, Marco J (1993) Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner — Study in the perfused rat pancreas. Regul Pept 43: 91–96
Leighton B, Cooper JS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632–635
Johnson KH, O'Brien TD, Jordan K, Betsholtz C, Westermark P (1990) The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose-tolerance in cats. Biochem Biophys Res Commun 167: 507–513
Molina JM, Cooper GJS, Leighton B, Olefsky JM (1990) Induction of insulin resistance in-vivo by amylin and calcitonin gene-related peptide. Diabetes 39: 260–265
Sowa R, Sanke T, Hirayama J et al. (1990) Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33: 118–120
Koopmans SJ, van Mansfeld ADM, Jansz HS et al. (1991) Amylin-induced in-vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia 34: 218–224
Bretherton-Watt D, Gilbey SG, Ghatei MA, Beacham J, Bloom SR (1990) Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man. Diabetologia 33: 115–117
O'Brien TD, Westermark P, Johnson KH (1990) Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin-secretion from isolated perfused rat pancreas. Biochem Biophys Res Commun 170: 1223–1228
Nagamatsu S, Carroll RJ, Grodsky GM, Steiner DF (1990) Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes 39: 871–874
Broderick CL, Brooke GS, DiMarchi RD, Gold G (1991) Human and rat amylin have no effects on insulin-secretion in isolated rat pancreatic-islets. Biochem Biophys Res Commun 177: 932–938
Kassir AA, Upadhyay AK, Lim TJ, Moosa AR, Olefsky JM (1991) Lack of effect of islet amyloid polypeptide in causing insulin resistance in conscious dogs during euglycaemic clamp studies. Diabetes 40: 998–1004
Ghatei MA, Datta HK, Zaidi M et al. (1990) Amylin and amylinamide lack an acute effect on blood glucose and insulin. J Endocrinol 124: R9-R11
Tedstone AE, Nezzer T, Hughes SJ, Clark A, Matthews DR (1990) The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro. Biosci Rep 10: 339–345
Ludvik B, Svoboda T, Hartter E et al. (1990) Basal and stimulated amylin levels in diabetes mellitus. Diabetologia 33: A39 (Abstract)
Eriksson J, Nakazato M, Miyazato M, Shiomi K, Matsukura S, Groop L (1992) Islet amyloid polypeptide: plasma-concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 291–293
Bretherton-Watt D, Ghatei MA, Bloom SR et al. (1989) Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia 32: 881–883
Gedulin B, Cooper GJS, Young AA (1991) Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. Biochem Biophys Res Commun 180: 782–789
Inoue K, Hisatomi A, Umeda F, Nawata H (1992) Effects of exogenous somatostatin and insulin on islet amyloid polypeptide (amylin) release from perfused rat pancreas. Hormone Metab Res 24: 251–253
Hanahan D (1985) Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315: 115–122
Bento Soares M, Schon E, Henderson A et al. (1985) RNA-mediated gene duplication: the rat preproinsulin I gene is a functional retroposon. Mol Cell Biol 5: 2090–2103
Mosselman S, Höppener JWM, Lips CJM, Jansz HS (1989) The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Lett 247: 154–158
van Mansfeld ADM, Mosselman S, Höppener JWM et al. (1990) Islet amyloid polypeptide — structure and upstream sequences of the IAPP gene in rat and man. Biochim Biophys Acta 1087: 235–240
Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD (1985) Factors affecting the efficiency of intruding foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82: 4438–4442
Laird PW, Zijderveld A, Linders K, Rudnicki M, Jaenisch R, Berns A (1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19: 4293
Bell GI, Picket RL, Rutter WJ, Cordell B, Tischer E, Goodman HM (1980) Sequence of the human insulin gene. Nature 284: 26–32
Stehouwer CDA, Lems WF, Fischer HRA, Hackeng WHL, Naass MAB (1989) Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin). Acta Endocrinol 121: 34–40
Bondar RJL, Mead DC (1974) Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem 20: 586–590
Lo D, Burkly LC, Widera G et al. (1988) Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 53: 159–168
Roman LM, Simons LF, Hammer RE, Sambrook JF, Gething M-JH (1991) The expression of influenza virus hemagglutinin in the pancreatic β-cells of transgenic mice results in autoimmune diabetes. Cell 61: 383–396
Hartter E, Svoboda T, Ludvik B et al. (1991) Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34: 52–54
Kreutter D, Orena SJ, Torchia AJ, Soeller W, Stevenson RW (1991) Amylin mRNA and plasma peptide levels in animal models of NIDDM. Diabetes 40: 159A (Abstract)
Tokuyama Y, Kanatsuka A, Ohsawa H et al. (1991) Hypersecretion of islet amyloid polypeptide from pancreatic islets of ventromedial hypothalamic-lesioned rats and obese Zucker rats. Endocrinology 128: 2739–2744
Huang H-JS, Young AA, Koda JE, Tulp OL, Johnson MJ, Cooper GJS (1992) Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp Rats. Hypertension 19: I-101–I-109
Alam T, Chen L, Ogawa A, Leffert JD, Unger RH, Luskey KL (1992) Coordinate regulation of amylin and insulin expression in response to hypoglycemia and fasting. Diabetes 41: 508–514
DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM — A balanced overview. Diabetes Care 15: 318–368
Clark A, Wells CA, Buley ID et al. (1988) Islet amyloid, increased A-cells, reduced β-cells and exocrine fibrosis: quantitative changes in the pancreas of ‘maturity onset’ diabetic patients. Diabetes Res 9: 151–160
de Koning EJP, Bodkin NL, Hansen BC, Clark A (1993) Diabetes melitus in Macaca mulatto monkeys is characterized by islet amyloidosis and reduction in beta-cell population. Diabetologia 36: 378–384
Clark A (1992) Islet amyloid: an enigma of type 2 diabetes. Diabetes Metab Rev 8: 117–132
Clark A, Edwards CA, Ostle LR et al. (1989) Localisation of islet amyloid polypeptide in lipofuscin bodies and secretory granules of human β-cells and in islets of type 2 diabetic subjects. Cell Tissue Res 257: 179–185
Clark A, Morris JF, Scott LA et al. (1991) Intracellular formation of amyloid fibrils in β-cells of human insulinoma and pre-diabetic monkey islets. In: Natvig JB, Forre O, Husby G et al. (eds) Amyloid and amyloidosis. Kluwer, Dordrecht, pp 453–456
Höppener JWM, Oosterwijk C, Visser-Vernooy HJ, Lips CJM, Jansz HS (1992) Characterization of the human islet amyloid polypeptide/amylin gene transcripts — identification of a new polyadenylation site. Biochem Biophys Res Commun 189: 1569–1577
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Höppener, J.W.M., Verbeek, J.S., de Koning, E.J.P. et al. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36, 1258–1265 (1993). https://doi.org/10.1007/BF00400803
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400803